The U.S. Food and Drug Administration (FDA) approved the first vaccine for humans specifically targeted against the H5N1 influenza virus — commonly known as avian or bird flu. In cases of H5N1 virus infection in humans, the disease caused by H5N1 was far more severe, with pneumonia and multi-organ failure commonly seen. The vaccine could…
Are you a Member of NAHC?
Become a member or sign in and read full NAHC Report articles at your leisure. Membership is affordable even if you're a small business and it comes with a lot of other benefits.